[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Tetracaine.]
[J05AF01, zidovudine, The metabolism of Fulvestrant can be increased when combined with Zidovudine.]
[J05AE02, indinavir, The metabolism of Fulvestrant can be decreased when combined with Indinavir.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Fulvestrant.]
[L01EX05, regorafenib, The metabolism of Fulvestrant can be decreased when combined with Regorafenib.]
[J05AE04, nelfinavir, The metabolism of Fulvestrant can be increased when combined with Nelfinavir.]
[G03XC05, ospemifene, The risk or severity of adverse effects can be increased when Fulvestrant is combined with Ospemifene.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Benzocaine.]
[L01EC02, dabrafenib, The metabolism of Fulvestrant can be decreased when combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Benzyl alcohol.]
[J05AP09, dasabuvir, The metabolism of Fulvestrant can be decreased when combined with Dasabuvir.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Bupivacaine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Oxybuprocaine.]
[J05AE09, tipranavir, The metabolism of Fulvestrant can be increased when combined with Tipranavir.]
[L01XX59, enasidenib, The metabolism of Fulvestrant can be decreased when combined with Enasidenib.]
[J05AG03, efavirenz, The metabolism of Fulvestrant can be increased when combined with Efavirenz.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Capsaicin.]
[A10BK04, ertugliflozin, The metabolism of Fulvestrant can be decreased when combined with Ertugliflozin.]
[N03AF01, carbamazepine, The metabolism of Fulvestrant can be increased when combined with Carbamazepine.]
[B02BX09, fostamatinib, The metabolism of Fulvestrant can be decreased when combined with Fostamatinib.]
[L01EB07, dacomitinib, The metabolism of Fulvestrant can be decreased when combined with Dacomitinib.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Chloroprocaine.]
[L01EX15, pexidartinib, The metabolism of Fulvestrant can be decreased when combined with Pexidartinib.]
[G03AC09, desogestrel, The metabolism of Fulvestrant can be increased when combined with Desogestrel.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Dyclonine.]
[L01EA06, asciminib, The metabolism of Fulvestrant can be decreased when combined with Asciminib.]
[B06AX04, mitapivat, The metabolism of Fulvestrant can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Levobupivacaine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Cocaine.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fulvestrant.]
[N03AX09, lamotrigine, The metabolism of Fulvestrant can be increased when combined with Lamotrigine.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Cinchocaine.]
[L01EB02, erlotinib, The metabolism of Fulvestrant can be decreased when combined with Erlotinib.]
[J05AE08, atazanavir, The metabolism of Fulvestrant can be decreased when combined with Atazanavir.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Pramocaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Diphenhydramine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Ropivacaine.]
[L02AA03, ethinyl estradiol, The metabolism of Fulvestrant can be increased when combined with Ethinylestradiol.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Etidocaine.]
[M01CB01, gold sodium thiomalate, The metabolism of Fulvestrant can be decreased when combined with Sodium aurothiomalate.]
[N05CD03, flunitrazepam, The metabolism of Fulvestrant can be decreased when combined with Flunitrazepam.]
[S01BC04, flurbiprofen, The metabolism of Fulvestrant can be decreased when combined with Flurbiprofen.]
[C10AB04, gemfibrozil, The metabolism of Fulvestrant can be decreased when combined with Gemfibrozil.]
[L01EX02, sorafenib, The metabolism of Fulvestrant can be decreased when combined with Sorafenib.]
[S01BC01, indomethacin, The metabolism of Fulvestrant can be decreased when combined with Indomethacin.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Articaine.]
[J02AB02, ketoconazole, The metabolism of Fulvestrant can be decreased when combined with Ketoconazole.]
[V03AC03, deferasirox, The metabolism of Fulvestrant can be decreased when combined with Deferasirox.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Lidocaine.]
[L01EA03, nilotinib, The metabolism of Fulvestrant can be decreased when combined with Nilotinib.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Mepivacaine.]
[N06AA09, amitriptyline, The metabolism of Fulvestrant can be decreased when combined with Amitriptyline.]
[B02BX05, eltrombopag, The metabolism of Fulvestrant can be decreased when combined with Eltrombopag.]
[L01EX03, pazopanib, The metabolism of Fulvestrant can be decreased when combined with Pazopanib.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Fulvestrant.]
[N03AA02, phenobarbital, The metabolism of Fulvestrant can be increased when combined with Phenobarbital.]
[N03AB02, phenytoin, The metabolism of Fulvestrant can be increased when combined with Phenytoin.]
[J05AE03, ritonavir, The metabolism of Fulvestrant can be increased when combined with Ritonavir.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Prilocaine.]
[N03AA03, primidone, The metabolism of Fulvestrant can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Fulvestrant can be decreased when combined with Probenecid.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Procaine.]
[N01AX10, propofol, The metabolism of Fulvestrant can be decreased when combined with Propofol.]
[J04AB02, rifampin, The metabolism of Fulvestrant can be increased when combined with Rifampicin.]
[N03AG01, valproic acid, The metabolism of Fulvestrant can be decreased when combined with Valproic acid.]
